Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00198393
Status:
COMPLETED
Last Update Posted:
2010-04-30
First Post:
2005-09-13
Brief Title:
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 23 Patients With NSCLC Stage IIIBIV
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Intergroupe Francophone de Cancerologie Thoracique
Organization Data
Organization:
Intergroupe Francophone de Cancerologie Thoracique
Class:
OTHER
Study ID:
IFCT-0301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Pr Jean-François Morère
Old Organization:
Intergroupe Francophone de Cancérologie Thoracique
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |
| AstraZeneca | INDUSTRY |